Your patient is receiving carmustine, a chemotherapy agent. A significant side effect of this medication is thrombocytopenia. What symptom would the nurse assess for in a patient at risk for thrombocytopenia?
A) Interrupted sleep pattern
B) Hot flashes
C) Nose bleed
D) Increased weight
Question 2
While a patient is receiving IV doxorubicin hydrochloride, the nurse observes that there is swelling and pain at the IV site. The nurse should:
A) Stop the administration of the drug immediately.
B) Notify the patient's health care provider.
C) Continue to administer but decrease the rate of infusion.
D) Apply a warm compress to the site.
Effect of clinical decison support systems
The reminder card should be completed and handed to the patient after the appointment is scheduled.
Positioning the Patient in the Fowler’s Position
Immunoconjugate drugs for targeted chemotherapy
The Coriolis Effect
Effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on bicarbonate secretion by gastric cells